ReviewCureus2026
Recent Advances in Gynaecological Care: Diagnostic Innovations, Therapeutic Strategies, and Patient Outcomes.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gynaecological care has advanced substantially through innovations in diagnostic imaging, molecular profiling, minimally invasive surgery, fertility preservation, targeted therapies, digital health, and patient-centred care. Despite these developments, major challenges remain, including delayed detection of ovarian and endometrial malignancies, unequal access to advanced technologies, limited long-term validation of emerging interventions, and inadequate integration of quality-of-life outcomes into routine clinical practice. This narrative review aimed to synthesise recent progress in gynaecological care with emphasis on diagnostic innovations, therapeutic strategies, and their influence on patient outcomes. Relevant peer-reviewed literature published between 2018 and 2026 was reviewed using major scientific databases, including PubMed, Scopus, Web of Science, and Google Scholar. The literature indicates that high-resolution ultrasound, MRI, molecular diagnostics, and artificial intelligence are strengthening disease characterisation and risk stratification, while liquid-biopsy approaches remain under investigation for molecular monitoring and other potential clinical applications. Robotic-assisted surgery, fertility-preserving approaches, immunotherapy, PARP inhibitors, and anti-angiogenic therapies are expanding individualised treatment options. Telemedicine, mobile health applications, and patient-reported outcome measures are also improving accessibility, engagement, and holistic care assessment. These advances collectively support a transition toward precision-oriented and patient-responsive gynaecological care. However, high costs, infrastructure limitations, ethical and regulatory concerns, unequal access, and the need for further clinical validation continue to restrict widespread implementation. Continued validation, multidisciplinary collaboration, and equitable healthcare strategies are essential to improve gynaecological outcomes globally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.